| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528159 e.g. N-[5-(2-Chloro-phenyl)-pyridin-2-yl]-5-fluoro-2-methyl-benzenesulfonamide; 11beta-hydroxysteroid dehydrogenases (11beta-HSD's) inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, metabolic syndrome, obesity |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528135 Pyridine derivatives as H3 antagonists |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2322953C Pyridine derivative and pharmaceutical containing the same |
| 05/05/2009 | CA2319005C 2-pyridylmethylamine derivatives useful as fungicides |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054792A1 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054742A2 Novel precursors |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009054434A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | WO2009054253A1 Organic electroluminescent device, display device and illuminating device |
| 04/30/2009 | WO2009054240A1 PROCESS FOR PRODUCTION OF DISULFONIC ACID COMPOUND, ASYMMETRIC MANNICH CATALYST, PROCESS FOR PRODUCTION OF β-AMINOCARBONYL DERIVATIVE, AND NOVEL DISULFONATE SALT |
| 04/30/2009 | WO2009054210A1 Process for producing toluidine compound |
| 04/30/2009 | WO2009053277A1 Aspartyl protease inhibitors |
| 04/30/2009 | WO2009053269A1 Novel kinase inhibitors |
| 04/30/2009 | WO2009053250A1 Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same |
| 04/30/2009 | WO2007056016A3 Bisamide cytokine inhibitors |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | US20090111983 Cycloalkylcarbonylamino Acid Derivative and Process For Producing The Same |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111828 L-alanine derivatives |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703797A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | CA2703307A1 Novel precursors |
| 04/30/2009 | CA2702269A1 Fungicidal compounds, processes for their preparation and their use for controlling harmful fungi, and compositions comprising them |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/30/2009 | CA2700915A1 Cyclohexeneamide derivatives and their use as trpv1 antagonist |
| 04/29/2009 | EP2053042A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2052252A1 Luminescent lanthanide labelling reagents and their use |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP2051969A1 Triazine derivative compound and composition for treating cancer containing them |
| 04/29/2009 | EP2051964A2 Fatty acid amide hydrolase inhibitors |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421243A Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/29/2009 | CN101421242A Dicarboxamide derivatives |
| 04/29/2009 | CN101421241A Pyridin-4 -ylmethylamides for combating pests |
| 04/29/2009 | CN101421240A Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN101417974A Antitumor compound Cu(C10H12NO2)2 |
| 04/29/2009 | CN101417973A Method for preparing 2,3,5,6-tetra aminopyridine-2,5-dihydroxy terephthalate |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482639C N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524968 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides |
| 04/28/2009 | US7524967 Process for producing 5-(2′-pyridyl)-2-pyridone derivative |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2424916C Novel synthesis of heteroarylamine intermediate compounds |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009052341A1 Gsm intermediates |
| 04/23/2009 | WO2009052334A1 Carbon linked modulators of y-secretase |
| 04/23/2009 | WO2009051848A1 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
| 04/23/2009 | WO2009051151A1 Therapeutic agent for trpv1-mediated disease |
| 04/23/2009 | WO2009050366A2 Arylamine synthesis method |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | WO2009049845A2 Bisamide derivatives and their use as insecticidal compounds |
| 04/23/2009 | WO2009049492A1 N-substituted aromatic hydrocarbon aniline and multi-substituted diarylether compounds, the preparation and the use of antitumor thereof |
| 04/23/2009 | WO2008133896A3 Dual-acting antihypertensive agents |
| 04/23/2009 | WO2007041494A3 Cholesteryl ester transfer protein inhibitors |
| 04/23/2009 | WO2007022532A3 Cyclopropyl compounds and compositions for delivering active agents |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105416 Synthesis of Vinylphenylpyridine and Living Anionic Polymerization |
| 04/23/2009 | US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 04/23/2009 | US20090105300 AMINE LINKED MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105288 CARBON LINKED MODULATORS OF gamma-SECRETASE |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105239 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 04/23/2009 | US20090105231 Amide derivatives as rock inhibitors |
| 04/23/2009 | US20090105203 Compounds for treating viral infections |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2703615A1 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
| 04/23/2009 | CA2702959A1 Carbon linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702911A1 Gsm intermediates |
| 04/23/2009 | CA2702455A1 Therapeutic agent for trpv1-mediated disease |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/22/2009 | EP2050737A1 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 04/22/2009 | EP2049535A1 Alpha-carboline derivatives and methods for preparation thereof |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049492A1 Process for quenching gaseous reaction product containing cyanopyridine |